Acusphere, Inc. (Public, OTC:ACUS) It is important to note that as with all FDA pending approvals, there is a tremendous amount of uncertainty. However, just remember that amongst uncertainty lies opportunity! That being said, continuing with the FDA journey to riches I have chosen ACUS as my next prime target. I see alot of benefit [...]
